methylprednisolone acetate has been researched along with Albers-Schoenberg Disease in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Aubaidi, Z | 1 |
Pedersen, NW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Results of Multiple Aspirations and Injections of Unicameral Bone Cyst by Methyl Prednisolone Acetate[NCT03724630] | 15 participants (Anticipated) | Observational | 2019-01-01 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for methylprednisolone acetate and Albers-Schoenberg Disease
Article | Year |
---|---|
A bone cyst treated with corticosteroid installation in an osteopetrotic child.
Topics: Anti-Inflammatory Agents; Bone Cysts; Child; Femur; Follow-Up Studies; Glucocorticoids; Humans; Inje | 2010 |